Aldeyra Therapeu (ALDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 18,008 | 9,394 | 6,098 | 9,550 | 10,343 |
| Operating Income | -18,008 | -9,394 | -6,098 | -9,550 | -10,343 |
| Interest Expense | 478 | 499 | 514 | 539 | 527 |
| Other Income | 1,638 | 1,810 | 1,859 | 1,902 | 1,883 |
| Pre-tax Income | -16,848 | -8,082 | -4,753 | -8,187 | -8,987 |
| Net Income Continuous | -16,848 | -8,082 | -4,753 | -8,187 | -8,987 |
| Net Income | $-16,848 | $-8,082 | $-4,753 | $-8,187 | $-8,987 |
| EPS Basic Total Ops | -0.28 | -0.14 | -0.08 | -0.14 | -0.15 |
| EPS Basic Continuous Ops | -0.28 | -0.14 | -0.08 | -0.14 | -0.15 |
| EPS Diluted Total Ops | -0.28 | -0.14 | -0.08 | -0.14 | -0.15 |
| EPS Diluted Continuous Ops | -0.28 | -0.14 | -0.08 | -0.14 | -0.15 |
| EPS Diluted Before Non-Recurring Items | -0.28 | -0.14 | -0.08 | N/A | N/A |
| EBITDA(a) | $-18,471 | $-9,505 | $-6,031 | $-9,485 | $-10,278 |